Content is available to registered users only. Registration is free.
Register now, or if you’ve already registered, log in.
Bailey Salimes, CRTonline.org
A half-dose of tenecteplase shows similar outcomes to primary percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients who are 60 years of age or older, a new analysis shows.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details